Teewinot Releases:
November 6, 2019 Teewinot Life Sciences to Participate at the 2nd Annual Cowen Cannabis Conference in Boston
October 17, 2019 Teewinot Announces Availability of Cannabinol for Commercial Cannabinoid Market
September 4, 2019 Teewinot Life Sciences Expands First In Class Intellectual Property Portfolio
May 22, 2019 Teewinot Life Sciences Announces Executive Leadership Changes
September 4, 2018 Teewinot Life Sciences Corporation Announced Today Grant Of A Canadian Patent With Broad Claims To Biosynthetic Production Of Cannabinoids
August 28, 2018 Teewinot Life Sciences Corporation Announced Today Grant of a U.S. Patent with Claims to Cannabinoid Formulations
November 27, 2017 Teewinot Life Sciences Corporation, a Global Leader in Pharmaceutical Cannabinoid Production, to Present at CBI’s Biopharma Forum on Cannabis-Based Therapies
May 22, 2017 Teewinot Life Sciences Corporation Announces New Cannabis Genome Research Program
March 20, 2017 Teewinot Life Sciences and Noramco sign letter of intent to produce cannabinoids with CannSynthesis™ biocatalysis technology
January 3, 2017 Teewinot Life Sciences’ Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures a New U.S. Patent for Biosynthesis of Cannabinoids
Teewinot in the News:
November 4, 2019 Teewinot Highlighted by Bloomberg Law for Intellectual Property Portfolio
September 10, 2019 Pharma’s Almanac Highlights Teewinot’s CannSynthesis® Platform And The Benefits Of Biosynthetic Cannabinoids
July 25, 2019 Teewinot CEO Michael Luther Interviewed on Daniel Levine’s “The Bio Report”
July 6, 2019 Teewinot CEO Michael Luther Highlighted in Marijuana Business Magazine “Industry Players”
February 8, 2018 Teewinot collects patents to make cannabinoids in US and Ireland
February 6, 2018 NetworkNewsAudio – Teewinot Life Sciences Corporation Interview
November 15, 2017 ALGAE DYNAMICS CORP SECURES US $250,000 INVESTMENT FROM TEEWINOT LIFE SCIENCES CORPORATION
July 11, 2017 Teewinot Life Sciences Corporation in the Tampa Bay Times, “One day, the Tampa Bay area will land its Chewy”
June 17, 2017 Teewinot Life Sciences Corporation’s Jeff Korentur in The Medicine Maker, “A View From the Biosynthetic Bridge”
June 2, 2017 Teewinot Life Sciences Corporation in PharmaTech, “Accessing Cannabinoids Using Biocatalysis”
February 22, 2017 Teewinot Life Sciences in CBInsights, “Grapeless Wine And Cowless Milk: 60+ Synthetic Biology Startups In A Market Map”
February 16, 2017 Teewinot Life Sciences in Outsourcing-Pharma, “Teewinot ups cannabinoid production capabilities”
February 14, 2017 Teewinot Life Sciences in PRN, “Teewinot Life Sciences Corporation Announces Breakthrough Commercial Production of the Cannabinoid Varin Series”
February 8, 2017 CEO, Jeffrey Korentur, quoted in in-Pharma, “Pot luck? Medical marijuana’s ‘questionable quality’ no threat to pharma R&D”
January 5, 2017 Patented biosynthesis produces ‘authentic, standardized cannabinoids’ for pharma
Media Relations Contact
Contact: Kellen Murphy
Email: kellen@tlscorp.com
Number: (813) 607-2909